文献速递瓣膜外科

三尖瓣反流与经导管主动脉瓣置换术后结局的关联:来自胸外科医师学会/美国心脏病学会经导管瓣膜治疗登记的报告

Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
PubMed 文献 · Ann Thorac Surg · 2018-03-02

该研究分析胸外科医师学会/美国心脏病学会经导管瓣膜治疗登记中2011年11月至2015年3月365家美国医院34,576例TAVR患者数据,评估术前三尖瓣反流严重程度与术后结局的关联;发现三尖瓣反流常见(80%),严重程度增加与合并症增多、STS预测死亡风险升高及1年死亡和心衰再入院风险增加相关,尤其对左心室射血分数大于30%的重度三尖瓣反流患者。

要点

  • TAVR患者中三尖瓣反流患病率80%,轻度56%、中度19%、重度5%。
  • 三尖瓣反流越重,STS预测死亡风险越高(无7.3±5.4至重度10.7±7.4,p<0.001)。
  • 左心室射血分数大于30%的重度三尖瓣反流患者1年死亡风险比1.29(95%CI 1.11-1.50)。

核心结论

  • 三尖瓣反流在TAVR患者中常见,严重程度增加与更高危患者及死亡和再入院增加相关,尤其对左心室射血分数大于30%的重度三尖瓣反流患者。
  • 对于主动脉瓣狭窄合并重度三尖瓣反流的患者,单纯TAVR的有效性可能需进一步考虑,尤其是较低危患者。

研究设计与样本

  • 回顾性分析胸外科医师学会/美国心脏病学会经导管瓣膜治疗登记中2011年11月至2015年3月365家美国医院34,576例TAVR患者数据。

主要发现

  • 三尖瓣反流存在于80%(n=27,804)的TAVR患者中,轻度56%(n=19,393)、中度19%(n=6,687)、重度5%(n=1,724)。
  • 三尖瓣反流严重程度增加与多种合并症相关,STS预测死亡风险升高(p<0.001):无三尖瓣反流7.3±5.4,轻度8.0±5.7,中度9.6±6.8,重度10.7±7.4。
  • 未调整分析中,中度和重度三尖瓣反流与体外循环使用增加、重症监护室和住院时间延长、新发透析、院内主要不良心脏事件、院内死亡、院内死亡观察值与预期值比值、长期心衰再入院和死亡增加相关(p<0.001)。
  • 调整后1年死亡在左心室射血分数大于30%的重度三尖瓣反流患者中显著更差(风险比1.29,95%CI 1.11-1.50),心衰再入院亦如此(风险比1.27,95%CI 1.04-1.54)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study is to evaluate the association of tricuspid regurgitation (TR) severity with outcomes after transcatheter aortic valve replacement (TAVR). METHODS: We analyzed data from 34,576 patients who underwent TAVR at 365 US hospitals from November 2011 through March 2015 submitted to The Society of Thoracic Surgeon/American College of Cardiology Transcatheter Valve Therapy Registry. We examined unadjusted mortality and heart failure readmission stratified by degree of preoperative TR and used multivariable models for 1-year mortality and heart failure readmission. RESULTS: Tricuspid regurgitation was present in 80% (n = 27,804) of TAVR patients, with mild TR in 56% (n = 19,393), moderate TR in 19% (n = 6687), and severe TR in 5% (n = 1,724). Increasing TR severity was associated with a number of comorbidities and The Society of Thoracic Surgeons predicted risk of mortality increased (p < 0.001): no TR (7.3 ± 5.4); mild TR (8.0 ± 5.7); moderate TR (9.6 ± 6.8); and severe TR (10.7 ± 7.4). In unadjusted analysis, moderate and severe TR were associated with increased use of cardiopulmonary bypass, longer intensive care unit and hospital stays, new dialysis, inhospital major adverse cardiac event, inhospital mortality, observed-to-expected inhospital mortality ratio, long-term heart failure readmission, and mortality (p < 0.001). Adjusted mortality at 1 year was significantly worse for patients with severe TR when left ventricular ejection fraction greater than 30% (hazard ratio 1.29, 95% confidence interval: 1.11 to 1.50) as was heart failure readmission (hazard ratio 1.27, 95% confidence interval: 1.04 to 1.54). CONCLUSIONS: Tricuspid regurgitation was common among patients undergoing TAVR. Increasing TR severity was associated with higher risk patients and increased mortality and readmission-particularly for patients with severe TR and left ventricular ejection fraction greater than 30%. The effectiveness of TAVR alone in patients with aortic stenosis and concomitant severe TR may warrant further consideration, particularly for lower risk patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. McCarthy FH, Vemulapalli S, Li Z, et al. Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. Ann Thorac Surg. 2018. PMID: 29502934. doi:10.1016/j.athoracsur.2017.11.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。